posted on
Apr 17, 2018 03:32PM
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Response to Koo's Zenith post on RVX
New Message
Please
login
to post a reply